An Open Label, Randomised, Single-centre, Two Sequence, Cross-over Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 microg, 400 microg and 2 x 400 microg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects Using a Population PK Approach
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 01 Oct 2012 Actual end date changed from Feb 2012 to Dec 2011 as reported by ClinicalTrials.gov.
- 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.